Moreover, there is no chance of needle injury with a needle-free injection system
It is the intake, the individualization, the quality of the compounded product, and the follow-up
If you notice any of these, do not use the vial
The key limitation of current Kisspeptin-10 research involves long term outcomes
The well-known geriatrician-haematologist Larry Solomon, working at Yale University in the USA, wrote 20 years ago: if I had treated only those people who actually had too low serum B12 and elevated MMA values, then I would not have treated approximately two-thirds of the people with a favourable response to B12 supplementation (note: partly via injections, partly via oral supplementation)
A lot of conventional doctors think this is all bullshit, he told me, smiling